OrsoBio
PrivateLast Round
Series B
Sep 6, 2024
Total Funding Raised
$166.3M
Company Overview
OrsoBio is a biopharmaceutical company that develops first-in-class therapies to treat severe metabolic disorders, including obesity, type 2 diabetes, MASH, and severe dyslipidemia.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OrsoBio Comparables
Compare OrsoBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rivus Pharmaceuticals | 86% | |
| Eolo Pharma | 79% | |
| AdipoPharma | 78% | |
OrsoBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 6, 2024 | ||||
| Series A | Nov 7, 2023 | ||||
| Grant | Nov 2, 2022 | ||||
| Seed | Nov 1, 2022 |
Key People
Founding team and executive leadership
OrsoBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series B, Series A |
| Enavate Sciences | Series B, Series A |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| Samsara BioCapital | Series A, Series B, Seed |
| Woodline Partners | Series B |
| NuevaBio | Series A, Seed, Series B |
| Ascenta Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors increased 79% MoM, reaching 3.8K.
- Sep 6, 2024
$67M round led by Ascenta Capital.
OrsoBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OrsoBio's valuation, stock price, and market status.